ArticleClinical obesity2026
Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories.
Article in Clinical obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a key risk factor for chronic disease and multimorbidity, yet variation in how obesity is defined may influence risk estimation in clinical practise. Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are better at capturing fat distribution than body mass index (BMI) and may have a role in obesity related multimorbidity prediction. To examine multimorbidity risk across obesity groups classified using BMI in combination with WHR/WHtR. A UK Biobank cohort free of comorbidity at baseline (n = 179 876) was followed for incident first long-term condition and multimorbidity (≥ 2 of 38 conditions) over a mean of 9.9 years. Six adiposity categories combining BMI with WHR/WHtR were analysed using Cox proportional hazards models. Subgroup analyses evaluated whether high central obesity (WHtR ≥ 0.6) provided additional risk stratification within BMI groups. Combined general with central obesity showed highest risk for the first condition (HR 1.11; 95% CI 1.087-1.138) and multimorbidity (HR 1.13; 95% CI 1.093-1.172). However, BMI-stratified subgroup analyses, central obesity provided additional risk discrimination only among individuals in the overweight category (BMI 25-29.9 kg/m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.